JP Morgan Chase
SNTI icon

JP Morgan Chase’s Senti Biosciences Holdings SNTI Stock Holding History

JP Morgan Chase’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9
Closed -$30 – 7599
2025
Q1 		$30 Buy
+9
New +$35 ﹤0.01% 7068
2024
Q1 		– Sell
-4
Closed -$28 – 7851
2023
Q4 		$28 Buy
4
+1
+33% +$4 ﹤0.01% 7292
2023
Q3 		$14 Buy
+3
New +$21 ﹤0.01% 7248
2022
Q2 		– Sell
-55,198
Closed -$5.45M – 6856
2022
Q1 		$5.45M Sell
55,198
-77,302
-58% -$7.63M ﹤0.01% 2942
2021
Q4 		$13.1M Buy
+132,500
New +$13.2M ﹤0.01% 2210
2021
Q3 		– Sell
-10
Closed -$1K – 6772
2021
Q2 		$1K Buy
+10
New +$998 ﹤0.01% 6267

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $42.8M AUM 15.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's SNTI Position: Q2 2025 in Review

JP Morgan Chase sold out of Senti Biosciences Holdings (SNTI) in Q2 2025, closing a stake of 9 shares — an estimated $30 sold.

JP Morgan Chase first reported a position in SNTI in Q2 2021 and held it in 6 quarters. The position peaked at $13.1M in Q4 2021. 15 funds tracked by Wall St. Rank hold SNTI as of Q2 2025.

  • JP Morgan Chase reported no remaining Senti Biosciences Holdings position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 9 Senti Biosciences Holdings shares in Q2 2025, an estimated $30.
  • JP Morgan Chase first reported a position in Senti Biosciences Holdings in Q2 2021 and held it in 6 quarters.
  • JP Morgan Chase's Senti Biosciences Holdings position peaked at $13.1M in Q4 2021.
  • 15 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.